MOUNJARO (TIRZEPATIDE) 10mg Injection provides a convenient, once-weekly solution for adults managing type 2 diabetes while aiming for weight loss. It activates both GLP-1 and GIP receptors, which enhances insulin production and helps reduce appetite. Consequently, patients can achieve better blood sugar control and improved metabolic health.
Benefits
The medication effectively manages blood sugar levels while supporting gradual, sustainable weight loss. Many patients notice steady improvements in glucose alongside reductions in body weight. Furthermore, the once-weekly injection schedule makes it easier for patients to stay consistent and maintain treatment.

